Compare Unichem Lab with Glenmark Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs GLENMARK PHARMA - Comparison Results

GLENMARK PHARMA 
   Change

Glenmark's focus areas are dermatology, gynecology, pediatrics and diabetics. The domestic formulations business contributed about 35% to revenues in FY07. On the international front, besides exports to the semi-regulated markets, the company has bee... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB GLENMARK PHARMA UNICHEM LAB/
GLENMARK PHARMA
 
P/E (TTM) x -102.3 11.7 - View Chart
P/BV x 0.6 1.7 33.4% View Chart
Dividend Yield % 2.5 0.6 411.2%  

Financials

 UNICHEM LAB   GLENMARK PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
GLENMARK PHARMA
Mar-19
UNICHEM LAB/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs292712 41.0%   
Low Rs182484 37.6%   
Sales per share (Unadj.) Rs167.7349.6 48.0%  
Earnings per share (Unadj.) Rs-3.632.8 -11.1%  
Cash flow per share (Unadj.) Rs5.944.3 13.4%  
Dividends per share (Unadj.) Rs4.002.00 200.0%  
Dividend yield (eoy) %1.70.3 504.3%  
Book value per share (Unadj.) Rs372.3198.6 187.4%  
Shares outstanding (eoy) m70.38282.17 24.9%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.41.7 82.7%   
Avg P/E ratio x-65.318.2 -358.1%  
P/CF ratio (eoy) x39.913.5 295.9%  
Price / Book Value ratio x0.63.0 21.2%  
Dividend payout %-110.26.1 -1,805.8%   
Avg Mkt Cap Rs m16,680168,625 9.9%   
No. of employees `0002.612.0 21.6%   
Total wages/salary Rs m2,39320,561 11.6%   
Avg. sales/employee Rs Th4,535.28,196.0 55.3%   
Avg. wages/employee Rs Th919.81,708.1 53.8%   
Avg. net profit/employee Rs Th-98.2768.5 -12.8%   
INCOME DATA
Net Sales Rs m11,80198,655 12.0%  
Other income Rs m9842,081 47.3%   
Total revenues Rs m12,785100,736 12.7%   
Gross profit Rs m-83515,858 -5.3%  
Depreciation Rs m6743,259 20.7%   
Interest Rs m753,346 2.2%   
Profit before tax Rs m-60011,335 -5.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m01,672 0.0%   
Tax Rs m-3433,756 -9.1%   
Profit after tax Rs m-2569,250 -2.8%  
Gross profit margin %-7.116.1 -44.0%  
Effective tax rate %57.333.1 172.8%   
Net profit margin %-2.29.4 -23.1%  
BALANCE SHEET DATA
Current assets Rs m20,38466,968 30.4%   
Current liabilities Rs m5,02940,211 12.5%   
Net working cap to sales %130.127.1 479.8%  
Current ratio x4.11.7 243.4%  
Inventory Days Days10583 125.7%  
Debtors Days Days13581 166.1%  
Net fixed assets Rs m9,02333,322 27.1%   
Share capital Rs m141282 49.9%   
"Free" reserves Rs m26,05855,770 46.7%   
Net worth Rs m26,19956,052 46.7%   
Long term debt Rs m035,738 0.0%   
Total assets Rs m31,496132,888 23.7%  
Interest coverage x-7.04.4 -159.0%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.40.7 50.5%   
Return on assets %-0.69.5 -6.0%  
Return on equity %-1.016.5 -5.9%  
Return on capital %-2.017.8 -11.2%  
Exports to sales %69.40-   
Imports to sales %00-   
Exports (fob) Rs m8,188NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m8,18862,998 13.0%   
Fx outflow Rs m59622,859 2.6%   
Net fx Rs m7,59240,140 18.9%   
CASH FLOW
From Operations Rs m-3,27813,242 -24.8%  
From Investments Rs m-2,860-6,990 40.9%  
From Financial Activity Rs m-24-7,387 0.3%  
Net Cashflow Rs m-4,690-2,971 157.9%  

Share Holding

Indian Promoters % 50.1 48.3 103.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 6.9 218.8%  
FIIs % 3.0 34.4 8.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 10.5 301.9%  
Shareholders   20,176 56,727 35.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   NATCO PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  TORRENT PHARMA  PANACEA BIOTECH  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 172 Points Higher; IT and Power Stocks Witness Buying(Closing)

Indian share markets continued to trade on a positive note during closing hours and ended their session near day's high.

Related Views on News

GLENMARK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of GLENMARK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

GLENMARK PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 53.1% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, GLENMARK PHARMA has posted a net profit of Rs 1 bn (down 53.1% YoY). Sales on the other hand came in at Rs 23 bn (up 7.3% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

GLENMARK PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 6.6% (Quarterly Result Update)

Jun 3, 2019 | Updated on Jun 3, 2019

For the quarter ended March 2019, GLENMARK PHARMA has posted a net profit of Rs 2 bn (up 6.6% YoY). Sales on the other hand came in at Rs 26 bn (up 12.4% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

More Views on News

Most Popular

A Simple, 7-Step Checklist for Your Trading Success

Dec 4, 2019

What we can learn from one of the greatest traders to have ever lived.

Use My Secret to Increase Your Trading Profits Today

Dec 10, 2019

What to do after every trade.

Growth Stocks or Value Stocks... What Will Make You More Money in this Bull Market?(Profit Hunter)

Nov 28, 2019

Should you invest in growth stocks or value stocks to make strong returns in this market?

Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020(Profit Hunter)

Dec 5, 2019

This corner of the market could provide more returns than blue chips in 2020.

What Is the IPO Euphoria Signaling Us About the Markets?(The 5 Minute Wrapup)

Dec 2, 2019

2019 will be remembered as the year of great money-making IPOs...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Dec 11, 2019 03:35 PM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS